Page 1 of 6
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. __)*
ORPHAN MEDICAL INC.
- --------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- --------------------------------------------------------------------------------
(Title of Class of Securities)
687303107
- --------------------------------------------------------------------------------
(CUSIP Number)
Paul T. Lambert, P.O. Box 11063, 103 Elk Run Way, Telluride, CO 81435
(970) 728-1777
- --------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
February 13, 1998
- --------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(d)(e), 13(d)-1(g), check the following box |__|.
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Rule 13d-7(b) for other
parties to whom copies are to be sent.
*The remainder of this cover page will be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
Page 2 of 6
SCHEDULE 13D
- -------------------------- --------------------------
CUSIP NO. 687303107 PAGE 2 OF 6 PAGES
- -------------------------- --------------------------
- --------------------------------------------------------------------------------
1 Name of Reporting Person
S.S. or I.R.S. Identification No. of Above Person
Paul T. Lambert (###-##-####)
- --------------------------------------------------------------------------------
2 Check The Appropriate Box if a Member of a Group* (a) |__|
(b) |__|
- --------------------------------------------------------------------------------
3 SEC Use Only
- --------------------------------------------------------------------------------
4 Source of Funds*
PF
- --------------------------------------------------------------------------------
5 Check Box if Disclosure of Legal Proceedings is Required
Pursuant to Item 2(d) or 2(e)* |__|
- --------------------------------------------------------------------------------
6 Citizenship or Place of Organization
United States
- --------------------------------------------------------------------------------
Number of 7 Sole Voting Power
Shares 325,000
Beneficially ----------------------------------------------------------------
Owned By Each 8 Shared Voting Power
Reporting None
Person With ----------------------------------------------------------------
9 Sole Dispositive Power
325,000
----------------------------------------------------------------
10 Shared Dispositive Power
None
- --------------------------------------------------------------------------------
11 Aggregate Amount Beneficially Owned by Each Reporting Person
325,000
- --------------------------------------------------------------------------------
12 Check Box if The Aggregate Amount in Row (11) Excludes Certain Shares*
|__|
- --------------------------------------------------------------------------------
13 Percent of Class Represented by Amount in Row (11)
5.4%
- --------------------------------------------------------------------------------
14 Type of Reporting Person*
IN
- --------------------------------------------------------------------------------
*See Instructions Before Filling Out!
Include Both Sides of the Cover Page, Responses to Items 1-7
- --------------------------------------------------------------------------------
<PAGE>
Page 3 of 6
ITEM 1. SECURITY AND ISSUER
The title of the class of equity securities to which this schedule relates
is common stock, par value $.01, of Orphan Medical Inc. (the "Issuer"). The
principal executive office and mailing address of the Issuer is 13911 Ridgedale
Drive #475, Minnetonka, MN 55305.
ITEM 2. IDENTITY AND BACKGROUND
The person filing this Schedule is Paul T. Lambert. Mr. Lambert's business
address is P.O. Box 11063, 103 Elk Run Way, Telluride, Colorado 81435 and his
occupation is real estate investment. Mr. Lambert is a United States citizen.
Mr. Lambert has not, during the last five years (excluding traffic
violations or similar misdemeanors), been convicted in a criminal proceeding or
been a party to a civil proceeding which involved a claimed violation of federal
or state securities laws.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
Mr. Lambert used personal funds to acquire the 325,000 shares of common
stock of the Issuer (the "Shares").
ITEM 4. PURPOSE OF TRANSACTION
Mr. Lambert acquired the Shares for personal investment.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
(a) Mr. Lambert owns an aggregate of 325,000 Shares, representing 5.4% of
the issued and outstanding stock of the Issuer.
(b) Mr. Lambert has the sole power to vote or to direct the vote, and the
sole power to dispose or to direct the disposition, of the Shares.
(c) Mr. Lambert effected the following transactions in the Shares during
the past sixty days:
# DATE P TRANSACTION SECURITY QTY PRICE
- ---- ------------- -------- --- -----
1 1/08/98 P Bought ORPH 2000 5 1/8
2 2/03/98 P Sold ORPH 2000 6 3/8
3 2/12/98 P Bought ORPH 1000 7 1/4
<PAGE>
Page 4 of 6
# DATE P TRANSACTION SECURITY QTY PRICE
- ---- ------------- -------- --- -----
4 2/12/98 P Bought ORPH 1000 7 1/4
5 2/13/98 P Bought ORPH 2000 7 1/4
6 2/13/98 P Bought ORPH 2000 7 1/4
7 2/13/98 P Bought ORPH 2000 7 1/4
8 2/13/98 P Bought ORPH 2000 7 1/4
9 2/13/98 P Bought ORPH 1450 7 3/8
10 2/17/98 P Bought ORPH 2500 7 5/8
11 2/17/98 P Bought ORPH 2000 7 5/8
12 2/17/98 P Bought ORPH 2500 7 5/8
13 2/17/98 P Bought ORPH 5000 7
All of the foregoing transactions were private transactions made by Mr.
Lambert for Mr. Lambert's personal investment with his personal funds.
(d) No person other than Mr. Lambert has the right to receive or the power
to direct the receipt of dividends from, or the proceeds from the sale of, the
Shares.
(e) Not applicable.
<PAGE>
Page 5 of 6
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO
SECURITIES OF THE ISSUER
There are no contracts, arrangements, understandings or relationships
(legal or otherwise) among the persons named in Item 2 or between such persons
and any person with respect to any securities of the Issuer. None of the Shares
are pledged or otherwise subject to a contingency, the occurrence of which would
give any person, other than Mr. Lambert voting power or investment power over
the Shares.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
No exhibits are filed as part of this Schedule 13D.
<PAGE>
Page 6 of 6
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this Schedule 13D is true, complete
and correct.
Dated: February 26, 1998
By /s/ Paul T. Lambert
---------------------------------
PAUL T. LAMBERT
